Creyon Bio

At Creyon, we are redefining what’s possible in RNA drug design. Creyon is an AI-driven drug development company creating tissue-specific, RNA-targeted nucleic acid therapies that are designed to be safer, more effective, and easier for patients to stay on. Our focus is on conditions where current RNA therapies face barriers to delivery and tolerability, including neuromuscular, central nervous system (CNS), and immunology disorders. Our mission is to unlock the full therapeutic potential of RNA medicines through intelligent design, precise delivery, and a deep understanding of tissue biology enabling better outcomes and improved quality of life for patients. Our vision is that the next generation of RNA medicines will be tissue-aware, computationally designed, and patient-centered, and we plan to lead that transformation bringing precision, predictability, and accessibility to RNA drug development.